Table 2 Table of the clinical features of the adopted dataset and their distributions.
Clinical feature | Distribution |
|---|---|
Recurrence | |
Yes (abs; %) | (40; 27.78%) |
No (abs; %) | (104; 72.22%) |
Age at histological diagnosis | |
Median [q1; q3] | 69 [64; 76] |
Weight (lbs) | |
Median [q1; q3] | 173.5 [145.13; 198.90] |
Nan (abs; %) | (10; 6.94%) |
Gender | |
Female (abs; %) | (36; 25%) |
Male (abs; %) | (108; 75%) |
Histology | |
Adenocarcinoma (abs; %) | (112; 77.77%) |
Squamous cell carcinoma (abs; %) | (29; 20.14%) |
Not otherwise specified (abs; %) | (3; 2.08%) |
Pathological T stage | |
T1 (abs; %) | (74; 51.39%) |
T2 (abs; %) | (49; 34.03%) |
T3 (abs; %) | (16; 11.11%) |
T4 (abs; %) | (5; 3.47%) |
Pathological N stage | |
N0 (abs; %) | (115; 79.86%) |
N1 (abs; %) | (12; 8.33%) |
N2 (abs; %) | (17; 11.8%) |
Histopathological grade | |
G1 (abs; %) | (37; 25.69%) |
G2 (abs; %) | (80; 55.56%) |
G3 Poorly differentiated (abs; %) | (27; 18.75%) |
Lymphovascular invasion | |
Absent (abs; %) | (121; 84.03%) |
Present (abs; %) | (18; 12.5%) |
Not Collected (abs; %) | (5; 3.47%) |
Pleural invasion | |
No (abs; %) | (105; 72.92%) |
Yes (abs; %) | (39; 27.08%) |
